AMYRIS INC (AMRS)
US03236M2008 - Common Stock
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Investors will want to get ready for another busy day of trading as we cover the biggest pre-market stock movers for Wednesday!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting the week off right with a breakdown of the biggest pre-market stock movers worth knowing about on Monday morning!
Friday Sector Leaders: Chemicals, Agriculture & Farm Products
AMRS Stock Surges 152% as Amyris Files for Bankruptcy
Amyris (AMRS) stock is rising higher on Friday with heavy trading after the biotechnology company recently filed for bankruptcy.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday!
RBLX Stock Alert: Roblox Scores Upgrade Despite Weak Q2 Results
Roblox (RBLX) stock is on the rise Thursday as investors in the video game company react to an upgrade from Wedbush analyst Nick McKay.
What Is Going on With Applied UV (AUVI) Stock Today?
Applied UV (AUVI) stock is on the move Thursday as investors react to the disinfectant company getting $4 million in orders.
Why Is Amyris (AMRS) Stock Down 67% Today?
Amyris (AMRS) stock is falling on Thursday after the company filed for Chapter 11 bankruptcy protection to facilitate a restructuring.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off the day with a breakdown of the biggest pre-market stock movers traders should watch on Thursday morning!
Amyris files for Chapter 11 bankruptcy (NASDAQ:AMRS)
Amyris (AMRS) said it filed Chapter 11 bankruptcy proceedings and is planning to sell its consumer brands to improve the company's liquidity position.
AMYRIS ANNOUNCES OPERATIONAL AND FINANCIAL RESTRUCTURING TO ADVANCE STRATEGIC TRANSFORMATION
/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris" or the "Company"), a leading synthetic biotechnology company accelerating the world's transition to...
Noteworthy Tuesday Option Activity: AMRS, CLDT, IAC
7 Biotech Stocks to Sell in July
Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July.
Is It Time to Buy This Year's Worst-Performing Growth Stocks?
Ready to make sense of the market's laggards? The share prices of these high-octane growth stocks are falling in 2023, so it might be time to bet on rebounds -- but only some of them.
AMYRIS ANNOUNCES CEO TRANSITION AND GLOBAL REDUCTION IN FORCE
/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through...
Commit To Buy Amyris At $0.50, Earn 40% Using Options
Amyris drops 11%, announces capital structure transformation (NASDAQ:AMRS)
Synthetic biotechnology company, Amyris (AMRS) Board of Directors will execute on a transformation program to accelerate improvements to the company's cost and capital structure...
AMYRIS INITIATES STRATEGIC TRANSFORMATION PROGRAM AND SECURES FUNDING
/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through...
AMYRIS COMPLETES LICENSE FOR SUPPLY OF SUSTAINABLE SQUALENE
EMERYVILLE, Calif., May 19, 2023 Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable...